📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase. (2021)

First Author: Mina JGM

Attributed to: Realising Unmet Potential in Translational Medical Science at Durham funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acsinfecdis.0c00546

PubMed Identifier: 33291887

Publication URI: http://europepmc.org/abstract/MED/33291887

Type: Journal Article/Review

Volume: 7

Parent Publication: ACS infectious diseases

Issue: 1

ISSN: 2373-8227